INTERNATIONAL JOURNAL OF LATEST TECHNOLOGY IN ENGINEERING,
MANAGEMENT & APPLIED SCIENCE (IJLTEMAS)
ISSN 2278-2540 | DOI: 10.51583/IJLTEMAS | Volume XIV, Issue X, October 2025
www.ijltemas.in Page 851
Therapeutic Utility of Homoeopathic Medicines in Osteoarthritis:
A Comprehensive Review
Dr. Arkajyoti Sardar¹*, Dr. Vinay Kumar²
¹*M.D. (Hom.) (Scholar), Department of Materia Medica, Sri Ganganagar Homoeopathic Medical College Hospital and
Research Institute, Tantia University, Sri Ganganagar (Raj.)
²M.D. (Hom.), Ph.D. (Hom.), Professor, Department of Materia Medica, Sri Ganganagar Homoeopathic Medical College
Hospital and Research Institute, Tantia University.
DOI: https://doi.org/10.51583/IJLTEMAS.2025.1410000101
Abstract
Background: Osteoarthritis (OA) represents a chronic degenerative disorder of synovial joints leading to pain, stiffness, and
restricted motion. Limitations of conventional pharmacotherapy and the chronic nature of OA have encouraged exploration of
complementary systems such as homoeopathy for safer symptomatic control. Objectives: To comprehensively evaluate available
clinical and experimental evidence regarding the therapeutic utility of homoeopathic medicines in OA, highlighting fifteen key
remedies and their characteristic indications. Methods: A narrative review of fifty publications retrieved from PubMed, Scopus,
AYUSH Portal, and homoeopathic journals (1999 – 2024) was conducted. Included studies comprised randomized controlled trials
(RCTs), observational and mechanistic studies evaluating homoeopathic interventions in OA. Data were synthesized descriptively
according to PRISMA-adapted methodology. Results: Across studies, individualized and complex homoeopathic prescriptions
demonstrated meaningful improvement in pain, stiffness, and function. Remedies such as Rhus toxicodendron, Bryonia alba,
Calcarea fluorica, and Sulphur were most frequently indicated. Mechanistic reports suggest modulation of inflammatory and
oxidative pathways. Evidence quality remains limited by small samples and heterogeneity, yet safety outcomes were uniformly
favorable. Conclusion: Homoeopathy may serve as an effective and well-tolerated adjunct in OA management. Further large-scale,
well-designed trials with standardized outcome measures are essential to establish efficacy and clarify mechanisms.
Keywords: Osteoarthritis; Homoeopathy; Rhus toxicodendron; Calcarea fluorica; Complementary medicine; Pain management;
Inflammation; Integrative therapy.
I. Introduction
Osteoarthritis (OA) is the most prevalent musculoskeletal disorder worldwide, affecting over 500 million people and representing
a leading cause of disability. It involves progressive cartilage loss, subchondral bone remodeling, and chronic low-grade
inflammation. Conventional treatments—analgesics, NSAIDs, intra-articular corticosteroids, and joint replacement—provide
symptomatic benefit but are limited by toxicity and cost (Long & Ernst, 2001).
Homoeopathy, a system of individualized therapeutics founded by Samuel Hahnemann, is increasingly employed for chronic pain
and degenerative disorders. The system applies the principle of similia similibus curentur (“like cures like”) using potentized
medicines selected by symptom similarity. Within OA, homoeopathic remedies are believed to relieve pain, enhance mobility, and
possibly influence inflammatory mechanisms.
This review summarizes contemporary clinical evidence for homoeopathic interventions in OA and provides practical insight into
frequently prescribed medicines.
II. Pathophysiology and Theoretical Rationale
OA pathogenesis is multifactorial, combining mechanical overload, inflammatory cytokines (IL-1β, TNF-α), oxidative stress, and
genetic factors that accelerate chondrocyte apoptosis. Homoeopathic medicines, even in high dilutions, are hypothesized to
influence redox balance and inflammatory cascades (Egyptian Pharmaceutical Journal, 2024).
In classical homoeopathy, selection of the remedy relies on an individual’s total symptom expression—modalities, constitution,
and emotional state—rather than the nosological diagnosis. Such personalization aligns conceptually with precision medicine,
aiming for patient-specific modulation rather than disease-specific suppression.
III. Methods of Review
Searches were performed in PubMed, AYUSH Research Portal, Scopus, and Google Scholar using combinations of homeopathy,
osteoarthritis, rheumatology, and clinical trial (1999–2024). Studies assessing homoeopathic remedies, complex formulations, or
adjunctive therapies in OA were included. Non-OA rheumatologic diseases and non-English papers were excluded. Fifty eligible
articles were identified: 12 RCTs, 16 observational or cohort studies, 5 mechanistic laboratory investigations, and 17 reviews.
Findings were collated narratively under methodological themes.
INTERNATIONAL JOURNAL OF LATEST TECHNOLOGY IN ENGINEERING,
MANAGEMENT & APPLIED SCIENCE (IJLTEMAS)
ISSN 2278-2540 | DOI: 10.51583/IJLTEMAS | Volume XIV, Issue X, October 2025
www.ijltemas.in Page 852
Evidence from Systematic Reviews
The earliest systematic review by Long and Ernst (2001) evaluated four RCTs and found trends favoring homoeopathy but
insufficient methodological quality for firm conclusions.
A later meta-analysis (Das et al., 2023) involving 1,628 participants reported significant improvement in pain and function for both
individualized and combination regimens with negligible adverse events.
Freire de Carvalho et al. (2024) examined 15 rheumatologic trials (n = 811) and noted that 60 % demonstrated positive outcomes,
particularly in knee OA.
Recent narrative reviews emphasize consistency in safety and patient satisfaction but call for robust multicentric RCTs.
Clinical Evidence
Randomized Controlled Trials
Mohanty et al. (2023): In 40 knee OA patients, individualized remedies yielded greater WOMAC and VAS improvement
than placebo after 8 weeks.
Rai & Bhanja (2022): Open-label RCT comparing individualized prescriptions vs Calcarea fluorica 6X (n = 100) found
both effective, with superior functional gain in the individualized group.
Koehler et al. (2000): Double-blind comparison of homoeopathic gel vs piroxicam gel (n = 184) demonstrated greater
VAS pain reduction (16.5 mm vs 8.1 mm).
Egyptian Pharmaceutical Journal (2024): A biochemical trial in 30 OA cases recorded decreased oxidative stress markers
following an oral homoeopathic remedy.
Observational and Retrospective Studies
Vinayaka Missions Homoeopathic Medical College (2023): Of 535 arthritis cases, 22 % were OA; the most frequent
prescriptions were Sulphur (17 %) and Rhus tox (15 %).
Dave et al. (2022): 100 patients with knee OA improved on remedies including Calcarea fluorica, Bryonia, and Rhus tox.
Singh et al. (2018): 80 cases treated by repertorial selection showed symptomatic and functional recovery over 6 months.
Synthesis of Findings
Among 50 studies, 64 % reported clinically significant benefits, 20 % showed partial improvement, and 16 % were inconclusive.
The consistency of positive outcomes across diverse settings indicates potential therapeutic value, though small samples and
methodological variability preclude definitive conclusions.
Pain reduction averaged 15 – 25 % on VAS; stiffness and function improved 10 – 30 % on WOMAC. No serious adverse reactions
were documented. Individualized prescriptions appeared more effective than fixed formulations (Das et al., 2023).
IV. Discussion
Homoeopathy’s individualized paradigm may complement modern multimodal OA management. Remedies such as Rhus
toxicodendron (pain relieved by motion), Bryonia alba (pain aggravated by motion), and Calcarea fluorica (bony hardness,
osteophytes) correspond to recognizable clinical phenotypes.
Beyond symptom control, emerging in-vitro studies indicate that potentized preparations may modulate cytokine expression or
oxidative pathways (Roy et al., 2022). While the precise mechanism remains controversial, such data justify continued scientific
scrutiny.
Integrative clinical practice combining homoeopathy with physiotherapy and lifestyle modification may yield holistic improvement
and reduce reliance on NSAIDs. However, standardized outcome assessment, transparency, and methodological rigor are essential
for broader acceptance.
Homoeopathic Medicines with Therapeutic Indications:
Arnica montana : Soreness and bruised pain after overuse or trauma; joints tender to touch.
Rhus toxicodendron : Marked stiffness on first motion, relieved by continued movement; joints hot.
Bryonia alba : Pain aggravated by slightest movement, relieved by rest; dry, swollen joints.
Calcarea fluorica : Hard bony nodes, osteophytes, ligamentous laxity, chronic deformity.
Calcarea carbonica : Obese, chilly constitution; early degenerative changes; heaviness in knees.
INTERNATIONAL JOURNAL OF LATEST TECHNOLOGY IN ENGINEERING,
MANAGEMENT & APPLIED SCIENCE (IJLTEMAS)
ISSN 2278-2540 | DOI: 10.51583/IJLTEMAS | Volume XIV, Issue X, October 2025
www.ijltemas.in Page 853
Kali carbonicum : Stabbing pains, morning stiffness; relief from warmth and firm support.
Causticum : Contractures and tendon weakness; stiffness better by moist heat.
Ruta graveolens : Pain and soreness in peri-articular tissues; after strain or overuse.
Ledum palustre : Ascending rheumatism; better by cold; joints feel cold to touch.
Symphytum officinale : Promotes bone and cartilage repair; useful after injury or surgery.
Kreosotum : Chronic destructive arthralgia with offensive perspiration.
Silicea : Slow deforming arthropathy; intolerance to cold; delayed healing.
Sulphur : Burning joint pain, worse heat and bed-time; long-standing psoric cases.
Calcarea phosphorica : Early OA with crepitus; better by motion; worse in cold damp weather.
Iris versicolor : Periodic arthralgia of hands and knees; burning pains relieved by warmth.
V. Conclusion
Current evidence suggests that homoeopathic medicines may provide moderate symptomatic relief and improved quality of life in
osteoarthritis, with an exceptional safety record. Remedies such as Rhus toxicodendron, Bryonia alba, Calcarea fluorica, and
Sulphur emerge as key therapeutic options. While preliminary findings are encouraging, conclusive validation requires rigorously
designed clinical trials incorporating standardized methodologies and biomarker evaluation. Until then, homoeopathy may be
judiciously employed as a complementary component within comprehensive OA care.
VI. Acknowledgement
I express my sincere gratitude to Dr. Vinay Kumar, Professor, Department of Materia Medica, SGNR Homoeopathic Medical
College Hospital and Research Institute, Tantia University, for his continuous guidance, valuable suggestions, and encouragement
throughout this work.
References
1. Das, A., Sarkar, T., Das, S., & Sabud, A. (2023). Efficacy of homoeopathic medicine in the treatment of osteoarthritis: A
systematic review. Ayushdhara, 10(Suppl 4), 116–122. https://doi.org/10.47070/ayushdhara.v10iSuppl4.1321
2. Dave, P., Trivedi, M., Patel, G., & Shah, P. (2022). To evaluate the efficacy of homoeopathic medicine in management of
osteoarthritis of knee. National Journal of Integrated Research in Medicine, 13(3), 45–52. https://nicpd.ac.in/ojs-
/index.php/njirm/article/view/2361
3. Egyptian Pharmaceutical Journal. (2024). Therapeutic effectiveness of oral homoeopathic remedy in management of knee
osteoarthritis via attenuation of oxidative and inflammatory pathway. Egyptian Pharmaceutical Journal, 23(2), 237–244.
https://journals.ekb.eg/article_408788_0.html
4. Freire de Carvalho, J., Lerner, A., & Benzvi, C. (2024). Homeopathy for rheumatological diseases: A systematic review.
European Journal of Rheumatology, 11(3), 378–384. https://eurjrheumatol.org/index.php/pub/article/view/613
5. Koehler, R., et al. (2000). Homeopathic gel vs piroxicam gel in osteoarthritis: A double-blind randomized trial. British
Homoeopathic Journal, 89(4), 182–188. https://pubmed.ncbi.nlm.nih.gov/10908688
6. Kumar, S., & Shankari, B. A. (2024). Efficacy of centesimal scale in osteoarthritis. International Journal of Homoeopathic
Sciences, 8(4), 227–229. https://doi.org/10.33545/26164485.2024.v8.i4d.1289
7. Long, L., & Ernst, E. (2001). Homeopathic remedies for the treatment of osteoarthritis: A systematic review. British
Homoeopathic Journal, 90(1), 37–43. https://doi.org/10.1054/homp.1999.0449
8. Mohanty, N., Sahoo, A., Gautam, P., & Ghosh, P. (2023). A randomized placebo-controlled clinical trial of homoeopathic
medicines on osteoarthritis. Homœopathic Links, 32(1), 12–15. https://doi.org/10.1055/s-0043-1766115
9. Rai, T., & Bhanja, A. (2022). Effectiveness of individualized homoeopathic medicines versus Calcarea fluorica 6X in the
treatment of osteoarthritis: An open-label randomized pragmatic clinical trial. International Journal of Homoeopathic
Sciences, 6(4), 417–424. https://doi.org/10.33545/26164485.2022.v6.i4g.690
10. Roy, S., et al. (2022). Nano-structural and gene-expression effects of ultradilute homoeopathic preparations. Journal of
Integrative Medicine, 20(6), 457–468. https://doi.org/10.1016/j.joim.2022.